Bruce Mitlak
About
Bruce Mitlak is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology.
According to data from OpenAlex, Bruce Mitlak has authored 97 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Orthopedics and Sports Medicine, 50 papers in Oncology and 37 papers in Molecular Biology. Recurrent topics in Bruce Mitlak's work include Bone health and osteoporosis research (76 papers), Bone health and treatments (48 papers) and Bone Metabolism and Diseases (34 papers). Bruce Mitlak is often cited by papers focused on Bone health and osteoporosis research (76 papers), Bone health and treatments (48 papers) and Bone Metabolism and Diseases (34 papers). Bruce Mitlak collaborates with scholars based in United States, United Kingdom and France. Bruce Mitlak's co-authors include Ouhong Wang, Harry K. Genant, Robert M. Neer, Erik Fink Eriksen, Jean‐Yves Reginster, Pierre D. Delmas, José Zanchetta, Claus Christiansen, Richard L. Prince and Sophia Ish‐Shalom and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
In The Last Decade
Bruce Mitlak
96 papers receiving 10.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Bruce Mitlak United States | 40 | 6.9k | 5.5k | 4.1k | 2.2k | 2.0k | 97 | 11.1k | ||
| José Zanchetta Argentina | 42 | 8.4k 1.2× | 6.6k 1.2× | 5.1k 1.2× | 1.5k 0.7× | 2.0k 1.0× | 114 | 12.3k | ||
| Steven T. Harris United States | 39 | 9.7k 1.4× | 6.2k 1.1× | 3.9k 0.9× | 1.1k 0.5× | 2.9k 1.5× | 76 | 12.9k | ||
| Henry G. Bone United States | 55 | 7.7k 1.1× | 7.6k 1.4× | 5.1k 1.2× | 915 0.4× | 1.7k 0.9× | 148 | 12.3k | ||
| Silvano Adami Italy | 46 | 4.9k 0.7× | 4.1k 0.8× | 2.9k 0.7× | 864 0.4× | 1.3k 0.6× | 142 | 8.5k | ||
| Arthur C. Santora United States | 38 | 8.4k 1.2× | 6.2k 1.1× | 3.3k 0.8× | 723 0.3× | 2.1k 1.1× | 93 | 10.4k | ||
| David Karpf United States | 24 | 5.8k 0.8× | 4.2k 0.8× | 2.5k 0.6× | 761 0.3× | 1.7k 0.9× | 38 | 7.6k | ||
| S. Adámi Italy | 46 | 4.8k 0.7× | 3.6k 0.7× | 2.0k 0.5× | 583 0.3× | 1.1k 0.6× | 165 | 7.4k | ||
| Robert W. Downs United States | 33 | 3.5k 0.5× | 2.9k 0.5× | 2.3k 0.6× | 1.1k 0.5× | 1.2k 0.6× | 69 | 6.6k | ||
| Claude D. Arnaud United States | 46 | 3.8k 0.6× | 4.0k 0.7× | 3.3k 0.8× | 1.4k 0.6× | 1.3k 0.6× | 95 | 9.0k | ||
| Davide Gatti Italy | 49 | 3.0k 0.4× | 2.0k 0.4× | 1.6k 0.4× | 990 0.4× | 859 0.4× | 283 | 7.4k |
Countries citing papers authored by Bruce Mitlak
Since
Specialization
Citations
This map shows the geographic impact of Bruce Mitlak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Mitlak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Mitlak more than expected).
Fields of papers citing papers by Bruce Mitlak
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Bruce Mitlak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Mitlak. The network helps show where Bruce Mitlak may publish in the future.
Co-authorship network of co-authors of Bruce Mitlak
This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Mitlak. A scholar is included among the top collaborators of Bruce Mitlak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Mitlak. Bruce Mitlak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Shiba, Takahiko, Tobias Fretwurst, Bruce Mitlak, et al.. (2025). Abaloparatide Enhances Bone Regeneration in Extraction Socket Dental Implant Defects: An Experimental In Vivo Study. Clinical Oral Implants Research. 36(4). 471–480.
2.
Eastell, Richard, Jacques P. Brown, Robert A. Adler, et al.. (2025). Bone turnover markers predict changes in bone mineral density in men treated with abaloparatide: results from the abaloparatide for the treatment of men with osteoporosis (ATOM) study. Journal of Bone and Mineral Research. 40(3). 315–322.
3.
Lewiecki, E. Michael, E. J. Czerwiński, Chris Recknor, et al.. (2023). Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized Study. Journal of Bone and Mineral Research. 38(10). 1404–1414.
4.
Cosman, Felicia, et al.. (2022). Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study. Osteoporosis International. 33(8). 1703–1714.
5.
Miller, Paul D., Steven Troy, R. J. Weiss, et al.. (2021). Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density. Clinical Drug Investigation. 41(3). 277–285.
6.
Cosman, Felicia, Linda R. Peterson, Dwight A. Towler, et al.. (2020). Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial. The Journal of Clinical Endocrinology & Metabolism. 105(11). 3384–3395.
7.
Czerwiński, E. J., José Cardona, Chris Recknor, et al.. (2020). The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial. Journal of Bone and Mineral Research. 37(12). 2435–2442.
8.
Eastell, Richard, et al.. (2019). Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE. Osteoporosis International. 30(3). 667–673.
9.
Bone, Henry G., Felicia Cosman, Paul D. Miller, et al.. (2018). ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 103(8). 2949–2957.
10.
Chandler, Heidi, Beate Lanske, Aurore Varela, et al.. (2018). Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption. Bone. 120. 148–155.
11.
Harvey, Nicholas C., J. A. Kanis, Alkım Öden Akman, et al.. (2015). FRAX and the effect of teriparatide on vertebral and non-vertebral fracture. Osteoporosis International. 26(11). 2677–2684.
12.
Bruyère, Olivier, John А. Kanis, Maria Luisa Brandi, et al.. (2010). The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). Osteoporosis International. 21(5). 713–722.
13.
Goldhahn, Jörg, Bruce Mitlak, Per Aspenberg, et al.. (2008). Critical Issues in Translational and Clinical Research for the Study of New Technologies to Enhance Bone Repair. Journal of Bone and Joint Surgery. 90(Supplement_1). 43–47.
14.
Alkhiary, Yaser M., Louis C. Gerstenfeld, Elizabeth A. Krall, et al.. (2005). Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34). Journal of Bone and Joint Surgery. 87(4). 731–741.
15.
Neer, Robert M., Catherine Arnaud, José Zanchetta, et al.. (2001). 骨粗鬆症の閉経後女性において骨折と骨密度に対する副甲状腺ホルモン(1-34)の効果. New England Journal of Medicine. 344(19). 1434–1441.
16.
Neer, Robert M., Claude D. Arnaud, José Zanchetta, et al.. (2001). Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis. New England Journal of Medicine. 344(19). 1434–1441.
17.
Ettinger, Bruce, Dennis M. Black, Bruce Mitlak, et al.. (2000). Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial. Obstetrical & Gynecological Survey. 55(1). 39–39.
18.
Johnston, C. Conrad, Nina H. Bjarnason, Fredric J. Cohen, et al.. (2000). Long-term Effects of Raloxifene on Bone Mineral Density, Bone Turnover, and Serum Lipid Levels in Early Postmenopausal Women. Archives of Internal Medicine. 160(22). 3444–3444.
19.
Cohen, Fredric J., Stephen Eckert, & Bruce Mitlak. (1998). Geographic Differences in Bone Turnover: Data from a Multinational Study in Healthy Postmenopausal Women. Calcified Tissue International. 63(4). 277–282.
20.
Mitlak, Bruce & Fredric J. Cohen. (1997). In Search of Optimal Long-Term Female Hormone Replacement: The Potential of Selective Estrogen Receptor Modulators. Hormone Research. 48(4). 155–163.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by José Zanchetta Breakdown of academic impact, for papers by Steven T. Harris Breakdown of academic impact, for papers by Henry G. Bone Breakdown of academic impact, for papers by Silvano Adami Breakdown of academic impact, for papers by Arthur C. Santora Breakdown of academic impact, for papers by David Karpf Breakdown of academic impact, for papers by S. Adámi Breakdown of academic impact, for papers by Robert W. Downs Breakdown of academic impact, for papers by Claude D. Arnaud Breakdown of academic impact, for papers by Davide Gatti